Dr. Neil White & Dr. Bess Marshall

Washington University School Of Medicine

The study of liraglutide (Victoza) in Wolfram Syndrome that is being conducted by Drs. White and Marshall at Washington University has gotten off to a slow start because of the COVID-19 pandemic. However, they have now recruited 10 subjects who are in various stages of recruitment, screening or treatment.  Two have already started treatment and eight more should be starting soon.  If you are interested in participating, please contact Dr. White (white_n@wustl.edu or 314-286-1156) or Dr. Marshall (bmarshall@wustl.edu).